You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Zanubrutinib

Showing 26 - 50 of 104
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Primary CNS Lymphoma, Secondary CNS Lymphoma, Relapsed Cancer Trial in Miami (drug, procedure, radiation)

Not yet recruiting
  • Primary Central Nervous System Lymphoma
  • +3 more
  • Miami, Florida
    Miami Cancer Institute at Baptist Health, Inc.
Dec 23, 2022

Diffuse Large B Cell Lymphoma Trial in Shanghai (Zanubrutinib, Polatuzumab Vedotin, Rituximab)

Recruiting
  • Diffuse Large B Cell Lymphoma
  • Zanubrutinib, Polatuzumab Vedotin, Rituximab
  • Shanghai, Shanghai, China
    Zhongshan Hospital，Fudan University
Jul 10, 2023

Mantle Cell Lymphoma, Newly-diagnosed Mantle Cell Lymphoma Trial in Guangzhou (Zanubrutinib and Rituximab, R-DHAOx, Zanubrutinib

Recruiting
  • Mantle Cell Lymphoma
  • Newly-diagnosed Mantle Cell Lymphoma
  • Zanubrutinib and Rituximab
  • +2 more
  • Guangzhou, Guangdong, China
  • +2 more
May 6, 2022

Relapsed/Refractory Marginal Zone Lymphoma Trial in Westbury (Zanubrutinib, Rituximab, Lenalidomide)

Recruiting
  • Relapsed/Refractory Follicular Lymphoma
  • Marginal Zone Lymphoma
  • Zanubrutinib
  • +3 more
  • Westbury, New York
    Clinical Research Alliance, Inc.
Nov 14, 2022

HLH Trial in Beijing (Zanubrutinib)

Recruiting
  • HLH
  • Zanubrutinib
  • Beijing, China
    Beijing Friendship Hospital, Capital Medical University
Apr 2, 2022

Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Newly Diagnosed Trial in Tianjin (Zanubrutinib, Fludarabine,

Not yet recruiting
  • Chronic Lymphocytic Leukemia
  • +2 more
  • Zanubrutinib, Fludarabine, cyclophosphamide and rituximab
  • Zanubrutinib, bendamustine, rituximab
  • Tianjin, Tianjin, China
    Institute of Hematology & Blood Diseases Hospital
Mar 18, 2022

Neuromyelitis Optica Trial in Beijing (zanubrutinib)

Recruiting
  • Neuromyelitis Optica
  • zanubrutinib
  • Beijing, Beijing, China
    XuanWu Hospital
May 15, 2022

Secondary CNS Lymphoma Trial in Beijing (Zanubrutinib, high-dose methotrexate (HD-MTX), rituximab)

Recruiting
  • Secondary Central Nervous System Lymphoma
  • Zanubrutinib, high-dose methotrexate (HD-MTX), rituximab
  • Beijing, Beijing, China
    Peking University Cancer Hospital & Institute
May 25, 2022

Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Duarte (procedure, biological, drug)

Not yet recruiting
  • Chronic Lymphocytic Leukemia
  • Small Lymphocytic Lymphoma
  • Biospecimen Collection
  • +4 more
  • Duarte, California
    City of Hope Medical Center
Jan 30, 2023

Relapsed or Refractory B-cell Non-Hodgkin Lymphoma Trial in Suzhou (Obinutuzumab, Zanubrutinib, Lenalidomide)

Enrolling by invitation
  • Relapsed or Refractory B-cell Non-Hodgkin Lymphoma
  • Suzhou, Jiangsu, China
    the First Affiliated Hospital of Soochow University
Mar 22, 2023

Zanubrutinib in Waldenström's Macroglobulinemia (ARIADNE)

Recruiting
  • Waldenström's Macroglobulinemia
  • Zanubrutinib
  • Salzburg, Austria
  • +1 more
May 2, 2022

Lupus Nephritis Trial in Guangdong (Zanubrutinib, Placebo)

Recruiting
  • Lupus Nephritis
  • Zanubrutinib
  • Placebo
  • Guangdong, Guangzhou, China
    Guangdong General Hospital
Apr 19, 2022

Immune Thrombocytopenia, Bruton Tyrosine Kinase Trial in Beijing (Zanubrutinib)

Recruiting
  • Immune Thrombocytopenia
  • Bruton Tyrosine Kinase
  • Zanubrutinib
  • Beijing, Beijing, China
    Peking University Insititute of Hematology, Peking University Pe
Mar 6, 2022

Overall Survival Trial in Qingdao (Rituximab + zanubrutinib + lenalidomide)

Recruiting
  • Overall Survival
  • Rituximab + zanubrutinib + lenalidomide
  • Qingdao, Shandong, China
    Qingdao central Hospital
May 22, 2022

Immune Thrombocytopenia, Treatment Trial in Tianjin (Zanubrutinib)

Recruiting
  • Immune Thrombocytopenia
  • Treatment
  • Zanubrutinib
  • Tianjin, Tianjin, China
    Chinese Academy of Medical Science and Blood Disease Hospital
Jan 19, 2022

Immune Thrombocytopenia Trial (Zanubrutinib, Dexamethasone)

Not yet recruiting
  • Immune Thrombocytopenia
  • (no location specified)
May 6, 2022

B-cell Malignancies Trial in Australia (Zanubrutinib, Fluconazole, Diltiazem)

Completed
  • B-cell Malignancies
  • Zanubrutinib
  • +4 more
  • Concord, New South Wales, Australia
  • +6 more
Jul 18, 2022

Immune Thrombocytopenia Trial in Beijing (Zanubrutinib, Eltrombopag)

Not yet recruiting
  • Immune Thrombocytopenia
  • Beijing, Beijing, China
    Peking University Insititute of Hematology, Peking University Pe
May 6, 2022

Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma Trial in Boston (Venetoclax, Zanubrutinib)

Recruiting
  • Chronic Lymphocytic Leukemia (CLL)
  • Small Lymphocytic Lymphoma
  • Boston, Massachusetts
  • +2 more
Mar 16, 2022

Recurrent Refractory Mantle Cell Lymphoma

Recruiting
  • Mantle Cell Lymphoma
    • Beijing, Beijing, China
      Peking University Third Hospital
    Aug 1, 2022

    Diffuse Large B-cell Lymphoma(DLBCL) Trial in Shanghai (Zanubrutinib + R-CHOP)

    Recruiting
    • Diffuse Large B-cell Lymphoma(DLBCL)
    • Zanubrutinib + R-CHOP
    • Shanghai, China
      Fudan University Shanghai Cancer Center
    Feb 10, 2022

    Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Leukemia (SLL) Trial in United States (Zanubrutinib, Obinutuzumab,

    Recruiting
    • Chronic Lymphocytic Leukemia (CLL)
    • Small Lymphocytic Leukemia (SLL)
    • Zanubrutinib
    • +2 more
    • Evanston, Illinois
    • +7 more
    Sep 9, 2022

    Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Trial in Houston (Rituximab, Zanubrutinib)

    Recruiting
    • Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
    • Rituximab
    • Zanubrutinib
    • Houston, Texas
      M D Anderson Cancer Center
    Jul 9, 2022

    Diffuse Large B Cell Lymphoma, CD79A Gene Mutation, CD79B Gene Mutation Trial in Zhengzhou (Rituximab, Zanubrutinib,

    Recruiting
    • Diffuse Large B Cell Lymphoma
    • +2 more
    • Zhengzhou, Henan, China
      Henan Cancer Hospital/The affiliated Cancer Hospital of ZhengZho
    Jan 22, 2022

    Diffuse Large B Cell Lymphoma Trial in Shanghai (zanubrutinib)

    Recruiting
    • Diffuse Large B Cell Lymphoma
    • zanubrutinib
    • Shanghai, Shanghai, China
      Fudan University Shanghai Cancer Center
    Mar 13, 2022